Economic Outcomes

Restrictive blood transfusion practices are associated with improved patient outcomes. (odpre novo okno)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Vir‎: Transfusion 2014;54(10 Pt 2):2753-9.

Indeksirano‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (odpre novo okno)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (odpre novo okno)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Vir‎: Transfusion 2017;57(6):1347-58.

Indeksirano‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (odpre novo okno)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (odpre novo okno)

MacLaren R, Sullivan PW.

Vir‎: Value Health 2005;8(2):105-16.

Indeksirano‎: PubMed 15804319

DOI‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (odpre novo okno)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (odpre novo okno)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Vir‎: Transfusion 2015;55(12):2807-15.

Indeksirano‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (odpre novo okno)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (odpre novo okno)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Vir‎: Crit Care 2015;19:83.

Indeksirano‎: PubMed 25880548

DOI‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (odpre novo okno)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (odpre novo okno)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Vir‎: Health Technol Assess 2013;17(10):1-79.

Indeksirano‎: PubMed 23477634

DOI‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (odpre novo okno)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (odpre novo okno)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Vir‎: J Trauma 2009;66(1):63-72.

Indeksirano‎: PubMed 19131807

DOI‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (odpre novo okno)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (odpre novo okno)

Zilberberg MD, Shorr AF.

Vir‎: BMC Health Serv Res 2007;7:138.

Indeksirano‎: PubMed 17764560

DOI‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (odpre novo okno)

INTENZIVNA NEGA

Economic Outcomes

slovenščina

Economic Outcomes

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (odpre novo okno)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (odpre novo okno)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (odpre novo okno)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (odpre novo okno)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (odpre novo okno)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (odpre novo okno)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (odpre novo okno)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (odpre novo okno)

Odbori za stike z bolnišnicami (OSB)

Paketi informacij za zdravnike

Videoposnetki

Economic Outcomes

Izberite svoj jezik

Deli povezavo